Nanosonics Limited (ASX:NAN)
Australia · Delayed Price · Currency is AUD 3.810
+0.130 (3.53%)
Apr 8, 2026, 11:39 AM AEST
Nanosonics Market Cap
Nanosonics has a market cap or net worth of 1.1 billion as of April 7, 2026. Its market cap has decreased by -25.36% in one year.
Market Cap
1.10B
Enterprise Value
950.46M
Revenue
207.26M
Ranking
n/a
PE Ratio
55.34
Stock Price
3.81
Market Cap Chart
Since May 17, 2007, Nanosonics's market cap has increased from 151.14M to 1.10B, an increase of 630.18%. That is a compound annual growth rate of 11.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 1.10B | -8.43% |
| Dec 31, 2025 | 1.20B | 30.84% |
| Dec 31, 2024 | 920.45M | -30.92% |
| Dec 29, 2023 | 1.33B | 2.84% |
| Dec 30, 2022 | 1.30B | -31.96% |
| Dec 31, 2021 | 1.90B | -21.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 66.66B |
| Sigma Healthcare | 30.60B |
| Pro Medicus | 12.42B |
| Cochlear | 11.27B |
| Regis Healthcare | 1.84B |
| Neuren Pharmaceuticals | 1.52B |
| Clarity Pharmaceuticals | 1.17B |
| PYC Therapeutics | 1.10B |